Sam Chun Dang Pharm Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sam Chun Dang Pharm Co Ltd with three other
companies in this sector in South Korea:
Whanin Pharmaceutical Company Limited
sales of 141.38 billion Korean Won [US$132.47 million]
Myungmoon Pharmaceutical Company Limited
(142.18 billion Korean Won [US$133.22 million]
of which 97%
was Manufacture and Sale of Pharmaceuticals), and
Daehwa Pharmaceutical Company Limited
(142.29 billion Korean Won [US$133.32 million]
Sam Chun Dang Pharm Co Ltd reported sales of 147.37 billion Korean Won (US$138.09 million)
December of 2016.
increase of 11.6%
versus 2015, when the company's sales were 132.06 billion Korean Won.
This was the fourth straight year of sales growth at Sam Chun Dang Pharm Co Ltd.